CLINICAL SIGNIFICANCE OF TRAIL AND TRAIL RECEPTORS IN PATIENTS WITH HEAD AND NECK CANCER

Yoldas B., Ozer C., Ozen O., Canpolat T., Dogan I., Griffith T. S., ...Daha Fazla

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, cilt.33, sa.9, ss.1278-1284, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 9
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1002/hed.21598
  • Dergi Adı: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1278-1284
  • Anahtar Kelimeler: TRAIL, TRAIL receptor, molecular diagnostics, clinical and pathologic staging, head and neck cancer, APOPTOSIS-INDUCING LIGAND, NF-KAPPA-B, PANCREATIC DUCTAL ADENOCARCINOMA, PROSTATE CARCINOMA-CELLS, GENE-THERAPY, MEDIATED APOPTOSIS, LUNG-CANCER, EXPRESSION, DEATH, SURVIVAL
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a death ligand currently under clinical trials for cancer. The molecular profile of TRAIL and TRAIL receptors has not yet been mapped for patients with laryngeal squamous cell carcinoma (SCC) or patients with oral cavity squamous cell carcinoma (OCSCC).